Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01179516

Public ClinicalTrials.gov record NCT01179516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.

Study identification

NCT ID
NCT01179516
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
469 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
May 2012 (Actual)
Completion
Jun 2012 (Actual)
Last update posted
Dec 18, 2013

2010 – 2012

United States locations

U.S. sites
61
U.S. states
29
U.S. cities
61
Facility City State ZIP Site status
Not listed Little Rock Arkansas — —
Not listed Carson California — —
Not listed Cerritos California — —
Not listed El Centro California — —
Not listed Fresno California — —
Not listed Glendale California — —
Not listed Los Angeles California — —
Not listed Oakland California — —
Not listed Oceanside California — —
Not listed San Diego California — —
Not listed Santa Ana California — —
Not listed Sherman Oaks California — —
Not listed Stanford California — —
Not listed Upland California — —
Not listed Denver Colorado — —
Not listed Hartford Connecticut — —
Not listed Hockessin Delaware — —
Not listed Fort Walton Beach Florida — —
Not listed Kissimmee Florida — —
Not listed Miami Florida — —
Not listed Pompano Beach Florida — —
Not listed Atlanta Georgia — —
Not listed Hoffman Estates Illinois — —
Not listed Naperville Illinois — —
Not listed Oak Brook Illinois — —
Not listed Indianapolis Indiana — —
Not listed Lafayette Indiana — —
Not listed Newburgh Indiana — —
Not listed Prarie Ridge Kansas — —
Not listed Wichita Kansas — —
Not listed Baltimore Maryland — —
Not listed Fall River Massachusetts — —
Not listed Watertown Massachusetts — —
Not listed Clinton Township Michigan — —
Not listed St Louis Missouri — —
Not listed Las Vegas Nevada — —
Not listed Nashua New Hampshire — —
Not listed Albuquerque New Mexico — —
Not listed Staten Island New York — —
Not listed Avon Lake Ohio — —
Not listed Beachwood Ohio — —
Not listed Canton Ohio — —
Not listed Garfield Heights Ohio — —
Not listed Toledo Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Salem Oregon — —
Not listed Allentown Pennsylvania — —
Not listed Philadelphia Pennsylvania — —
Not listed Pittsburgh Pennsylvania — —
Not listed Lincoln Rhode Island — —
Not listed Columbia South Carolina — —
Not listed Franklin Tennessee — —
Not listed Dallas Texas — —
Not listed DeSoto Texas — —
Not listed Houston Texas — —
Not listed Lake Jackson Texas — —
Not listed San Antonio Texas — —
Not listed The Woodlands Texas — —
Not listed Salt Lake City Utah — —
Not listed Roanoke Virginia — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01179516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2013 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01179516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →